Confinia Cephalalgica

Confinia Cephalalgica, a peer-reviewed open access journal, focuses on publishing articles related to various aspects of headache medicine, including genetics, pathophysiology, diagnosis, imaging, management, epidemiology, pharmacology, and treatment. It covers both primary and secondary headaches, as well as other facial pains and their connections with systemic diseases. Confinia Cephalalgica highlights the historical context of scientific advancements in headache medicine, particularly the recent innovative investigations and their impact on migraine treatment. The journal aims to stay updated with rapidly evolving areas of medicine, such as digital health, gender medicine, and artificial intelligence, as applied to the field of headache medicine. The journal publishes quarterly issues containing various types of articles, including original and review articles, case reports, short communications, letters to the editor, and news items as "pros and cons" articles discussing controversial basic and clinical issues.

Confinia Cephalalgica is the official journal of the Italian Society for the Study of Headaches (SISC) with the overarching goal to serve as a forum for scientists and clinicians dedicated to headache medicine.

Announcements

Enrico Greppi Award for the Innovation in Headache Medicine

18-04-2025

Announcement of the Enrico Greppi Award for the Innovation in Headache Medicine
Call for Papers 2025 (April 23 - July 15 2025)

Confinia Cephalalgica is pleased to announce the Enrico Greppi Award (EG-Award), that, endorsed and funded by SISC, will be presented annually to promote excellence in headache research. The EG-Award will be granted annually to the best original research paper submitted under this specific call for submissions.

The EG-Award includes a € 5,000 prize, and public recognition through, in addition to the publication in Confinia Cephalalgica, the paper presentation to the annual SISC Congress - Parma, 6-8 November 2025.